Peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonists (thiazolidinediones)
have anti-inflammatory effects and improve endothelium function. Here, we analyzed the …

Peroxisome proliferator‐activated receptor gamma (PPAR‐γ) is a nuclear membrane‐
associated transcription factor that governs the expression of various inflammatory genes …

The present study addresses the neuroprotective function of intracerebroventricular (icv)
application of pioglitazone, a selective ligand of the peroxisome proliferator‐activated …

The neuroprotective effect of rosiglitazone, a peroxisome proliferator-activated receptor γ
(PPARγ) agonist, has been investigated using both in vivo and in vitro models of global …

Thiazolidinediones (TZDs), pioglitazone, rosiglitazone and troglitazone, the synthetic
agonists for the PPARγ, administered prior or during ischemic insult improve stroke outcome …

Background and Purpose—Oligodendrogenesis is essential for white matter repair after
stroke. Although agonists of peroxisome proliferator–activated receptors γ confer …

In this study, we examined whether rosiglitazone, a peroxisome proliferator-activated
receptor gamma (PPAR γ) agonist, is neuroprotective in focal ischemic brain injury, and …

Thiazolidinediones (TZDs) are synthetic agonists of the ligand‐activated transcription factor
peroxisome proliferator‐activated receptor‐γ (PPARγ). TZDs are known to curtail …

Stroke is a devastating disease with limited treatment options. Recently, we found that the
peroxisome proliferator‐activated receptor‐γ (PPARγ) agonists troglitazone and …

Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist, rosiglitazone, not only
improves insulin resistance in patients with type II diabetes but also exerts a broad spectrum …